ANEBULO PHARMACEUTICALS, INC. Increase (Decrease) in Due from Related Parties, Current
ANEBULO PHARMACEUTICALS, INC. (ANEB) reported Increase (Decrease) in Due from Related Parties, Current of -$3.50 thousand for the 6-month period ending 2020-12-31, per its 10-Q filed 2022-02-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent · last filed 2022-02-11
- 2020-12-31: Increase (Decrease) in Due from Related Parties, Current 6 month -$3.50K.
| Period end | Increase (Decrease) in Due from Related Parties, Current 6 month |
|---|---|
| 2020-12-31 | -$3.50K 10-Q · filed 2022-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |